Peer-reviewedCC BY-NC-NDAnnals of medicine and surgery (2012)
Evaluation of the efficacy of duloxetine and venlafaxine in chemotherapy-induced neuropathy in cancer patients: a double-blind multicenter randomized clinical trial
- 1Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran
- 2Department of Community Medicine, School of Medicine, Social Determinants of Health Research Center, Gonabad University of Medical Sciences, Gonabad, Iran
Related
- Topical herbal medicine as treatment for chemotherapy-induced peripheral neuropathy: a systematic review of randomized controlled trials
- Pharmacogenomic predictor of long-term residual chemotherapy-induced peripheral neuropathy in ovarian cancer survivors: A substudy of the GINECO Vivrovaire study
- Baseline Peripheral Neuropathy Predicts Clinically Significant Neuropathy During Paclitaxel Treatment Following Oxaliplatin-based Chemotherapy.
- Selected Ion Channels in Chemotherapy-Induced Peripheral Neuropathy: Mechanisms and Translational Limits
- miR-378f targets CAB39 to regulate autophagy in chemotherapy-induced peripheral neuropathy.
BibTeX
@article{shahini2026evaluation,
title = {{Evaluation of the efficacy of duloxetine and venlafaxine in chemotherapy-induced neuropathy in cancer patients: a double-blind multicenter randomized clinical trial}},
author = {Najmeh Shahini and Narges Lashkarbolouk and Saeede Khaki and Mahdi Mazandarani and Maliheh Ziaee},
journal = {Annals of medicine and surgery (2012)},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13657610},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Evaluation of the efficacy of duloxetine and venlafaxine in chemotherapy-induced neuropathy in cancer patients: a double-blind multicenter randomized clinical trial
AU - Najmeh Shahini
AU - Narges Lashkarbolouk
AU - Saeede Khaki
AU - Mahdi Mazandarani
AU - Maliheh Ziaee
PY - 2026
DA - 2026/09/03
JO - Annals of medicine and surgery (2012)
UR - https://europepmc.org/article/PMC/PMC13657610
SN - 2049-0801
ER -